16.79
전일 마감가:
$16.52
열려 있는:
$16.67
하루 거래량:
661.27K
Relative Volume:
0.85
시가총액:
$1.37B
수익:
$288.00K
순이익/손실:
$-228.06M
주가수익비율:
-3.9506
EPS:
-4.25
순현금흐름:
$-168.82M
1주 성능:
-2.04%
1개월 성능:
+14.06%
6개월 성능:
-8.80%
1년 성능:
+16.03%
Viridian Therapeutics Inc Stock (VRDN) Company Profile
명칭
Viridian Therapeutics Inc
전화
617.272.4600
주소
221 CRESCENT STREET, WALTHAM
VRDN을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
VRDN
Viridian Therapeutics Inc
|
16.79 | 1.40B | 288.00K | -228.06M | -168.82M | -4.25 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Viridian Therapeutics Inc Stock (VRDN) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-12-19 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
2024-11-25 | 개시 | TD Cowen | Buy |
2024-09-11 | 재확인 | Needham | Buy |
2024-06-11 | 개시 | Wolfe Research | Outperform |
2024-06-06 | 개시 | Goldman | Buy |
2024-05-09 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
2024-05-09 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
2023-06-14 | 개시 | BTIG Research | Buy |
2023-06-14 | 재개 | Credit Suisse | Outperform |
2023-05-30 | 개시 | RBC Capital Mkts | Outperform |
2023-04-17 | 개시 | Wells Fargo | Overweight |
2023-03-30 | 개시 | Stifel | Buy |
2022-12-19 | 개시 | Cowen | Outperform |
2022-12-19 | 개시 | Needham | Buy |
2022-12-16 | 개시 | Credit Suisse | Outperform |
2022-12-01 | 개시 | H.C. Wainwright | Buy |
2022-06-23 | 개시 | B. Riley Securities | Buy |
2021-11-18 | 개시 | SVB Leerink | Outperform |
2021-10-12 | 개시 | Evercore ISI | Outperform |
2021-01-25 | 개시 | Ladenburg Thalmann | Buy |
모두보기
Viridian Therapeutics Inc 주식(VRDN)의 최신 뉴스
Teacher Retirement System of Texas Decreases Stock Holdings in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World
Is Viridian Therapeutics Inc. a good long term investmentTremendous portfolio expansion - Autocar Professional
What drives Viridian Therapeutics Inc. stock priceSky-high return potential - Autocar Professional
Viridian Therapeutics Inc. Stock Analysis and ForecastPhenomenal capital gains - Autocar Professional
(VRDN) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
What analysts say about Viridian Therapeutics Inc. stockExtraordinary performance - jammulinksnews.com
Principal Financial Group Inc. Acquires 30,392 Shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World
Viridian Therapeutics’ Veligrotug Shows Durable Proptosis Response in Phase 3 TED Trial - MSN
13 Best Low Priced Pharma Stocks to Buy Now - Insider Monkey
Why Viridian Therapeutics Inc. stock attracts strong analyst attentionPortfolio Boosting Stock Alerts - Newser
What makes Viridian Therapeutics Inc. stock price move sharplyFast Moving Stock Alerts - Newser
How Viridian Therapeutics Inc. stock performs during market volatilitySafety First Trading Signals - Newser
Evercore Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Cuts Target Price to $38 - 富途牛牛
Amalgamated Bank Has $34,000 Stake in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World
Evercore ISI Lowers Viridian Therapeutics Price Target to $38 - AInvest
Viridian Therapeutics Sees Relative Strength Rating Improve To 79 - MSN
(VRDN) Investment Analysis - news.stocktradersdaily.com
Viridian Therapeutics, Inc. (NASDAQ:VRDN) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Viridian Therapeutics: Fueling R&D Breakthroughs Through Strategic Equity Incentives - AInvest
Is Viridian Therapeutics (NASDAQ:VRDN) A Risky Investment? - simplywall.st
(VRDN) On The My Stocks Page - news.stocktradersdaily.com
When (VRDN) Moves Investors should Listen - news.stocktradersdaily.com
Viridian Therapeutics, Inc. (NASDAQ:VRDN) Receives $37.56 Average Target Price from Analysts - Defense World
Viridian Therapeutics’ SWOT analysis: promising TED treatment stock faces pivotal year - Investing.com
Viridian Therapeutics, Inc. (NASDAQ:VRDN) Shares Purchased by California State Teachers Retirement System - Defense World
Viridian Therapeutics: The Song Remains The Same (NASDAQ:VRDN) - Seeking Alpha
Transcript : Viridian Therapeutics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 08 - MarketScreener
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $2.22 Million Stake in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World
Where are the Opportunities in (VRDN) - news.stocktradersdaily.com
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | VRDN Stock News - GuruFocus
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Viridian Therapeutics shares fall as Q1 loss narrows, revenue beats By Investing.com - Investing.com Nigeria
Ameriprise Financial Inc. Increases Stock Position in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World
Viridian Therapeutics to Participate in Upcoming June 2025 Investor Conferences - BioSpace
Viridian Therapeutics to Participate in Upcoming June Investor C - GuruFocus
Viridian Therapeutics to Participate in Upcoming June Investor Conferences - Business Wire
Bank of America Corp DE Grows Position in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Buys 13,990 Shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World
Viridian Therapeutics, Inc. (NASDAQ:VRDN) Stock Holdings Increased by Nuveen Asset Management LLC - Defense World
Viridian Therapeutics, Inc. (NASDAQ:VRDN) Shares Sold by Millennium Management LLC - Defense World
Viridian reports long-term durability data, secures FDA designation for TED therapy - Eyes On Eyecare
Viridian Therapeutics Inc (VRDN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):